ROIV – roivant sciences ltd. - common shares (US:NASDAQ)

News

Roivant Sciences Ltd. (ROIV): David Einhorn Trims Stake [Yahoo! Finance]
Roivant Sciences: Moderna Settlement And Brepocitinib Support A Long-Term Buy [Seeking Alpha]
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman [Yahoo! Finance]
Roivant Sciences (ROIV) was given a new $40.00 price target by Piper Sandler.
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com